Press release
Bayer and Regeneron "EYLEA" Market size expansion of Several Folds by 2034
Are you interested in finding out the projected market size of EYLEA in 2034? EYLEA Market Forecast
https://www.delveinsight.com/report-store/eylea-market-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Key Factors Driving EYLEA Growth
1. Market Share Gains and New Patient Starts
Indications:
• Wet age-related macular degeneration (wAMD)
• Diabetic macular edema (DME)
• Retinal vein occlusion (RVO)
US sales:
• ~$4.77B in 2024
• Total US franchise (EYLEA + HD):
• $5.97B in 2024
Implication:
• One of the largest ophthalmology markets globally
• Strong installed base of chronic patients requiring long-term therapy
2. Expansion Across Key Indications
High-dose (8 mg) version approved in 2023
2024 U.S. sales:
• ~$1.2B contribution
Growth trend:
• +29% YoY in Q2 2025
• +54% YoY in early 2025 data
The EYLEA Market Report offers projected sales forecasts for EYLEA for indications until 2034, categorized across the 7MM i.e. United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report also provides extensive coverage and a competitive landscape analysis of competitors and marketed products indication. It also covers analyst views along with market drivers and barriers.
Bayer and Regeneron's EYLEA is serving as a beacon of hope for the patients suffering from the Retinal Vein Occlusion.
What is a EYLEA Prescribed for?
EYLEA (aflibercept) is a prescription medication primarily used to treat various eye conditions caused by abnormal blood vessel growth or fluid leakage in the retina. It is commonly prescribed for:
• Wet Age-Related Macular Degeneration (wAMD): To slow vision loss caused by abnormal blood vessel growth under the retina.
• Diabetic Macular Edema (DME): To reduce retinal swelling and improve vision in patients with diabetes.
• Diabetic Retinopathy (DR): To prevent vision loss in patients with diabetic eye disease.
• Macular Edema following Retinal Vein Occlusion (RVO): To treat swelling and improve visual acuity after blockage of retinal veins.
The report extensively covers the details and developments related to EYLEA, capturing important highlights on developmental pipeline, regulatory status and special designations of EYLEA, route of administration, safety and efficacy details.
EYLEA Market Assessment
This report provides a detailed market assessment of EYLEA for Retinal Vein Occlusion in the seven major markets, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. This segment of the report provides forecasted sales data from 2028 to 2034.
EYLEA Clinical Assessment
The report provides the clinical trials information of EYLEA for Retinal Vein Occlusion covering trial interventions, trial conditions, trial status, start and completion dates. The report also includes important insights on regulatory milestones and other developmental activities related.
Do you know your drug's competitive positioning against EYLEA? EYLEA Drugs Insights
https://www.delveinsight.com/sample-request/eylea-market-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
EYLEA Recent Developments in the Treatment Landscape
• In February 2026, Regeneron Pharmaceuticals announced that it will present updates from its ophthalmology portfolio and pipeline at the virtual Angiogenesis, Exudation, and Degeneration (Angiogenesis) annual meeting in February 2026. The presentations will include new clinical data highlighting the efficacy and safety of EYLEA HD (aflibercept) Injection 8 mg for the treatment of patients with serious retinal disorders..
EYLEA Competitive Landscape
The report offers insights into the key players and companies actively engaged in the development of the specified indication. It provides valuable information regarding the competitive positioning of the EYLEA.
EYLEA Market Size in the US
A dedicated section of the report focuses on the expected market size of EYLEA for the United States. DelveInsight's analysis includes market trends, growth projections, and key factors influencing the market dynamics, offering a comprehensive perspective for stakeholders.
Key Highlights of EYLEA:
• The report contains forecasted sales of EYLEA for indication till 2034.
• Comprehensive coverage of the late-stage emerging therapies for Retinal Vein Occlusion.
• The report also features the qualitative and quantitative analysis with analysts as well as KOL views for EYLEA in Retinal Vein Occlusion.
Stay ahead in competition by leveraging insights on EYLEA market Report: Download EYLEA Market Report
https://www.delveinsight.com/sample-request/eylea-market-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Why you should buy EYLEA Market Report:
• The report provides future market assessments for EYLEA for Retinal Vein Occlusion in the 7 Major Markets, Advance qualitative analysis like SWOT, expert analysts' views, detailed overview of market competitors, and short analysis of other emerging therapies in Ulcerative Colitis.
• Leading EYLEA for Retinal Vein Occlusion forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the EYLEA
• Discover the competitive landscape of EYLEA through 7MM
• Get a Thorough Analysis of the EYLEA Development pipeline, Safety & Efficacy of the EYLEA, and ROA
• Thorough EYLEA market forecast will help understand how drug is competing with other emerging EYLEA
• Get analysis of the EYLEA clinical trial advancements and the detailed clinical assessment, regulatory and commercial assessment
• Drug Market forecasts are calculated after taking into consideration KOL viewpoints
Related Reports By DelveInsight:
Retinal Vein Occlusion Pipeline https://www.delveinsight.com/report-store/retinal-vein-occlusion-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's, "Retinal Vein Occlusion Pipeline Insight, 2026" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Retinal Vein Occlusion pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products.
It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bayer and Regeneron "EYLEA" Market size expansion of Several Folds by 2034 here
News-ID: 4438612 • Views: …
More Releases from DelveInsight Business Research
Sickle Cell Disease Market Poised for Sustained Growth Amid Advancements in Trea …
DelveInsight's comprehensive market research provides critical insights into such market trends, enabling stakeholders to understand growth drivers, emerging opportunities, and potential challenges within the Sickle Cell Disease landscape.
DelveInsight's report "Sickle Cell Disease Market Insights, Epidemiology, and Market Forecast-2034," provides a comprehensive analysis of the Sickle Cell Disease landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the prevalence, incidence, and patient demographics…
Rheumatoid Arthritis Pipeline 2026: MOA and ROA Insights, Clinical Trials Status …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Rheumatoid Arthritis pipeline constitutes 75+ key companies continuously working towards developing 80+ Rheumatoid Arthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Rheumatoid Arthritis Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Rheumatoid Arthritis Market.
The Rheumatoid…
Stargardt Disease Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Stargardt Disease pipeline constitutes 20+ key companies continuously working towards developing 20+ Stargardt Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Stargardt Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also…
Marginal Zone Lymphoma Market Analysis 2034: Industry Trends, Market Size, and E …
DelveInsight's "Marginal Zone Lymphoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Marginal Zone Lymphoma, historical and forecasted epidemiology as well as the Marginal Zone Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Marginal Zone Lymphoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Marginal Zone Lymphoma…
More Releases for EYLEA
Growth Patterns, Segment Analysis, and Competitive Approaches Influencing the Ey …
The Eylea market is poised for notable expansion in the coming years as advancements in treatment options and growing patient populations drive demand. This sector is experiencing dynamic shifts, influenced by innovation, accessibility improvements, and evolving therapeutic applications. Let's explore the market's size projections, major players, key trends, and segmentation details to understand its future trajectory.
Projected Growth and Market Size Outlook for Eylea
The Eylea market is forecasted to grow…
Eylea HD Market Overview, Key Trends, and Insights on Top Players
An Overview of the Eylea HD Market Outlook
The Eylea HD market is set for considerable growth by 2030, driven by various factors including an increase in diabetic retinopathy cases and the rising demand for long-acting formulations. Innovations in ocular drug delivery technologies, a growing elderly population, and the expansion of outpatient eye care facilities also contribute to this upward trend. Key developments expected during this period involve a shift…
Eylea Market Thrives On Addressing The Rise In Ocular Diseases: Transformative F …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Eylea Industry Market Size Be by 2025?
There has been a robust expansion in the eylea market size over the past few years. The market, which will rise from $9.94 billion in 2024, is projected to hit $10.51 billion in 2025, representing a compound annual growth…
Eylea Market Emerging Trends and Growth Prospects 2034
Eylea market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Eylea Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The…
Global EYLEA Drug Market Imapct of AI and Automation
EYLEA Drug Market Impact of AI and Automation
In 2022, the EYLEA drug market was valued at approximately $7.3 billion. The market is projected to experience a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. This growth trajectory highlights a robust expansion in the treatment of retinal diseases, reflecting both increasing patient populations and advancements in medical technology. The ultimate drivers of this growth include ongoing research and…
Eylea Market Growth, Trends & Competitive Analysis 2024-2033
The Business Research Company recently released a comprehensive report on the Global Eylea Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The eylea market size has…
